Drug Insights

Explore Tadalafil on Synapse: Tips and Tricks for Better Search Results

23 February 2024
2 min read

Tadalafil, marketed under the brand name Cialis,belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which also includes sildenafil (Viagra) and vardenafil (Levitra).Tadalafil was first approved by FDA for the treatment of erectile dysfunction (ED) on November 21, 2003. It was developed by the pharmaceutical company ICOS Corporation and marketed by Eli Lilly and Company. In addition to its approval for treating erectile dysfunction, tadalafil was also approved by the FDA for the treatment of benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension (PAH). Click on the image below to begin the exploration journey of Tadalafil through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Almirall Acquires Rights to Novo Nordisk's Anti-IL-21 for Dermatology
Latest Hotspot
3 min read
Almirall Acquires Rights to Novo Nordisk's Anti-IL-21 for Dermatology
23 February 2024
Almirall gains rights to develop Novo Nordisk’s anti-IL-21 antibody for dermatologic applications as a pioneering treatment.
Read →
An analysis of Apalutamide's R&D progress and its clinical results presented at the 2024 ASCO_GU Annual Meeting
An analysis of Apalutamide's R&D progress and its clinical results presented at the 2024 ASCO_GU Annual Meeting
23 February 2024
Early PSA response correlates with better outcomes in mHSPC patients receiving ADT and ARPIs.
Read →
Citius Pharma Resubmits LYMPHIR™ BLA for Treatment of Adult Relapsed/Refractory CTCL
Latest Hotspot
3 min read
Citius Pharma Resubmits LYMPHIR™ BLA for Treatment of Adult Relapsed/Refractory CTCL
22 February 2024
Citius Pharma re-submits its LYMPHIR™ BLA, comprising Denileukin Diftitox, aiming to treat relapsed/refractory Cutaneous T-Cell Lymphoma in adults.
Read →
Strategically Search Mupirocin on Synapse: A How-to Guide
Drug Insights
2 min read
Strategically Search Mupirocin on Synapse: A How-to Guide
22 February 2024
Mupirocin (BACTROBAN) is an antibiotic that blocks RNA synthetase and treats impetigo from Staph aureus and Streptococcus pyogenes when applied to the skin.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.